Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin ± Pembrolizumab.
Journal: European urology oncology
Published: March 20, 2026
Spatial Regulation of Lysosomal Vesicle Acidification Along the Axon via mRAVE-Dependent v-ATPase Assembly.
Journal: bioRxiv : the preprint server for biology
Published: January 09, 2026
Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 06, 2025
PARP inhibitors in gastric cancer: unlocking precision oncology.
Journal: The oncologist
Published: March 03, 2025
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer.
Journal: Current oncology reports
Published: January 27, 2025
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.
Journal: Nature communications
Published: September 18, 2024
A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapy.
Journal: bioRxiv : the preprint server for biology
Published: June 19, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.
Journal: The oncologist
Published: March 08, 2024
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer.
Journal: The Journal of clinical investigation
Published: December 18, 2023
Last Updated: 09/26/2026